Related Experiment Video
Updated: Aug 17, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X)
L Bjørkhaug1, H Ye, Y Horikawa
1Center for Medical Genetics and Molecular Medicine, University of Bergen, Bergen, N-5021, Norway.
Abstract:
Maturity-onset diabetes of the young (MODY) is an autosomal dominant form of diabetes characterized by early onset of pancreatic dysfunction. MODY type 3 is caused by mutations in the hepatocyte nuclear factor (HNF)-1alpha. During a screening of Norwegian patients with suspected MODY we identified two novel HNF-1alpha mutations, P112L and Q466X. The molecular mechanisms underlying the disease were studied by analyzing the DNA binding properties, transcriptional activation, and subcellular localization of HNF-1alpha P112L and Q466X compared to wild type HNF-1alpha. P112L had reduced ability to bind an HNF1 consensus sequence and to activate transcription. Q466X did not differ from wild type HNF-1alpha in DNA binding activity. Transactivation, however, was markedly reduced. When both mutants were coexpressed with wild type HNF-1alpha in HeLa cells, transcriptional activity appeared unaffected, suggesting that a dominant-negative mechanism was not present. Immunolocalization experiments showed that P112L HNF-1alpha was correctly targeted to nuclei in HeLa cells. In contrast, some Q466X HNF-1alpha protein was retained in the cytoplasm, which indicated that the mechanism for nuclear localization was disturbed. Thus, the HNF-1alpha mutations P112L and Q466X both seem to impair pancreatic beta-cell function by loss-of-function mechanisms; P112L by reduced DNA binding and reduced ability to transactivate, and Q466X by reduced transactivation and incomplete nuclear targeting.
Insights
Two novel mutations in the hepatocyte nuclear factor (HNF)-1alpha gene, P112L and Q466X, were identified in Norwegian patients with Maturity-onset diabetes of the young (MODY). These mutations impair pancreatic beta-cell function through loss-of-function mechanisms.
Area of Science:
- Genetics
- Molecular Biology
- Endocrinology
Background:
- Maturity-onset diabetes of the young (MODY) is an autosomal dominant form of diabetes.
- MODY type 3 is specifically linked to mutations in the hepatocyte nuclear factor (HNF)-1alpha gene.
- Understanding the molecular basis of HNF-1alpha mutations is crucial for diagnosing and managing MODY.
Purpose of the Study:
- To identify and characterize novel mutations in the HNF-1alpha gene in Norwegian MODY patients.
- To elucidate the molecular mechanisms by which these mutations lead to pancreatic beta-cell dysfunction.
- To investigate the impact of mutations on DNA binding, transcriptional activation, and subcellular localization of HNF-1alpha.
Main Methods:
- Screening of Norwegian patients for suspected MODY.
- Identification of two novel HNF-1alpha mutations: P112L and Q466X.
- Analysis of DNA binding, transcriptional activation, and subcellular localization of mutant HNF-1alpha proteins compared to wild type.
Main Results:
- P112L mutation showed reduced DNA binding and transcriptional activation.
- Q466X mutation exhibited reduced transactivation and incomplete nuclear localization.
- Neither mutation demonstrated a dominant-negative effect when coexpressed with wild-type HNF-1alpha.
Conclusions:
- Both P112L and Q466X mutations impair HNF-1alpha function through loss-of-function mechanisms.
- P112L affects DNA binding and transactivation, while Q466X impacts transactivation and nuclear targeting.
- These findings contribute to understanding the molecular pathology of MODY type 3 and the role of HNF-1alpha.
Related Concept Videos
Pleiotropy
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

